Chemoinformaics analysis of METHYL PYRIDINE-3-CARBOXYLATE
| Molecular Weight | 137.138 | nRot | 1 |
| Heavy Atom Molecular Weight | 130.082 | nRig | 7 |
| Exact Molecular Weight | 137.048 | nRing | 1 |
| Solubility: LogS | -0.241 | nHRing | 1 |
| Solubility: LogP | 0.661 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 19.0616 |
| nHD | 0 | BPOL | 10.7664 |
| QED | 0.539 |
| Synth | 1.576 |
| Natural Product Likeliness | -0.853 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.198 |
| MDCK | 0.0000341 |
| BBB | 0.935 |
| PPB | 0.393873 |
| VDSS | 1.219 |
| FU | 0.554728 |
| CYP1A2-inh | 0.889 |
| CYP1A2-sub | 0.785 |
| CYP2c19-inh | 0.34 |
| CYP2c19-sub | 0.522 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.401 |
| CYP2d6-inh | 0.046 |
| CYP2d6-sub | 0.412 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.271 |
| CL | 10.765 |
| T12 | 0.84 |
| hERG | 0.041 |
| Ames | 0.014 |
| ROA | 0.136 |
| SkinSen | 0.853 |
| Carcinogencity | 0.193 |
| EI | 0.982 |
| Respiratory | 0.07 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.883946 |